{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:37:13Z","timestamp":1699490233780},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T00:00:00Z","timestamp":1228867200000},"content-version":"vor","delay-in-days":9689,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver"],"published-print":{"date-parts":[[1982,6]]},"abstract":"<jats:p><jats:bold>ABSTRACT\u2014<\/jats:bold> To clarify the importance of ethnic and geographic factors in chronic active hepatitis (CAH), HBV markers and autoantibodies (AMA, ANA, SMA), have been compared in 158 patients with biopsy\u2010proven CAH from New York City and in 92 patients with CAH from Milan. HBsAg\u2010positive CAH was more frequently observed in Milan (49%) than in New York City (27%). However, among HBsAg\u2010positive patients, HBcAg, HBeAg, and epidemiologic risk factors for acquisition of HBV infection were more frequently found in New York than in Italy. The prevalence of HBsAg\u2010negative, anti\u2010HBc\u2010positive CAH and cryptogenic CAH was similar in the two cities, while autoimmune CAH was more frequently observed in New York (20%) than in Milan (2%). In particular, the prevalence of autoimmune hepatitis was higher among Jewish patients than among patients of Anglo\u2010Saxon or Latin ethnic background in New York. Thus, environmental and\/or ethnic factors may influence the prevalence of the four major types of CAH.<\/jats:p>","DOI":"10.1111\/j.1600-0676.1982.tb00187.x","type":"journal-article","created":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T18:45:58Z","timestamp":1281465958000},"page":"119-124","source":"Crossref","is-referenced-by-count":1,"title":["Geographic differences in HBV related, autoimmune, and cryptogenic chronic active hepatitis"],"prefix":"10.1111","volume":"2","author":[{"given":"E.","family":"Sagnelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Del Ninno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Vernace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Paronetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,10]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0016-5085(19)33297-4","article-title":"Occurrence of Australia antigen in chronic hepatitis in Italy","volume":"63","author":"Bianchi L.","year":"1972","journal-title":"Gastroenterology"},{"key":"e_1_2_1_3_2","first-page":"293","article-title":"Hepatitis B antigen in subjects and patients with liver disease: Result of collaborative study","volume":"52","author":"Nishioka K.","year":"1975","journal-title":"Bull WHO"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(69)90052-X"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)92534-8"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.1967.11696105"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/oxfordjournals.bmb.a070915","article-title":"Autoimmune aspects of liver disease","volume":"29","author":"Doniach D.","year":"1972","journal-title":"Br Med Bull"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.qjmed.a067264"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)33223-8"},{"key":"e_1_2_1_10_2","first-page":"131","article-title":"Treatment of chronic active hepatitis with either prednisolone or corticotrophin: A controlled trial","volume":"24","author":"Giusti G.","year":"1977","journal-title":"Acta Hepatogastroenterol (Stuttg)"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)92149-6"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91080-7"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1977.tb01077.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5931.604"},{"key":"e_1_2_1_15_2","unstructured":"ParonettoF. PiccininoF. VernaceS J SagnelliE. AloisioV. GiustiG. RubinsteinP.HLA antigens in HBsAg positive chronic active hepatitis (CAH): population and family studies. Proceedings of 1981 New York International Symposium on Viral Hepatitis New York March 30April 2 1981. in press."},{"key":"e_1_2_1_16_2","first-page":"8","volume-title":"Diseases of the liver and biliary tract","author":"Leevy C M","year":"1976"},{"key":"e_1_2_1_17_2","first-page":"25","article-title":"Staining methods of Australia antigen in paraffin section","volume":"44","author":"Shikata T.","year":"1974","journal-title":"Jap J Exp Med"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000149428"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/0016-5085(78)90471-7","article-title":"Dane particles\u2010associated hepatitis B core antigen in patients with HBsAg\u2010positive chronic hepatitis","volume":"75","author":"Sagnelli E.","year":"1978","journal-title":"Gastroenterology"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890020202"},{"key":"e_1_2_1_21_2","first-page":"71","article-title":"Heterogeneity and thermolability of \u201ce\u201d antigen","volume":"42","author":"Williams A.","year":"1975","journal-title":"Bibl Haematol"},{"key":"e_1_2_1_22_2","first-page":"237","article-title":"Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implication","volume":"1","author":"Doniach D.","year":"1966","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/35.1-2.176"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91567-2"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0016-5085(79)80165-1","article-title":"Acute non\u2010A, non\u2010B hepatitis: Prolonged presence of the infectious agent in blood","volume":"76","author":"Tabor E.","year":"1979","journal-title":"Gastroenterology"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)92280-3"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9071(1980)5:4<317::AID-JMV1890050408>3.0.CO;2-H"}],"container-title":["Liver"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0676.1982.tb00187.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0676.1982.tb00187.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T16:34:00Z","timestamp":1699461240000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0676.1982.tb00187.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,6]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1982,6]]}},"alternative-id":["10.1111\/j.1600-0676.1982.tb00187.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0676.1982.tb00187.x","archive":["Portico"],"relation":{},"ISSN":["0106-9543","1600-0676"],"issn-type":[{"value":"0106-9543","type":"print"},{"value":"1600-0676","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,6]]}}}